Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Journal of Immunology (Baltimore, Md. : 1950)|September 7, 2001
Human endothelial-cell specific molecule-1 binds directly to the integrin CD11a/CD18 (LFA-1) and blocks binding to intercellular adhesion molecule-1D Béchard, A Scherpereel, H Hammad, et al.
Revue De Pneumologie Clinique|February 5, 2013
[Castleman's disease: unusual presentation of Castleman's disease and review of literature]A Baranzelli, R Akkad, B Bouchindhomme, et al.
Revue Des Maladies Respiratoires|June 11, 2013
[Feasibility of assessing EGFR mutation and others using samples obtained by EBUS transbronchial needle aspiration]S Boulanger, C Delattre, C Descarpentries, et al.
Lung Cancer (Amsterdam, Netherlands)|June 19, 2012
Final results and pharmacoeconomic analysis of a trial comparing two neoadjuvant chemotherapy (CT) regimens followed by surgery in patients with resectable non-small cell lung cancer (NSCLC): a phase II randomised study by the European Lung Cancer Working PartyT Berghmans, J J Lafitte, V Giner, et al.
The European Respiratory Journal|June 10, 2010
Valproate-doxorubicin: promising therapy for progressing mesothelioma. A phase II studyA Scherpereel, T Berghmans, J J Lafitte, et al.
The European Respiratory Journal|May 31, 2011
Validation and comparison of several published prognostic systems for patients with small cell lung cancerM Paesmans, J J Lafitte, J Lecomte, et al.
The Journal of Biological Chemistry|October 9, 2001
Endocan is a novel chondroitin sulfate/dermatan sulfate proteoglycan that promotes hepatocyte growth factor/scatter factor mitogenic activityD Béchard, T Gentina, M Delehedde, et al.
Lung Cancer (Amsterdam, Netherlands)|September 7, 2013
Identification of microRNA-based signatures for response and survival for non-small cell lung cancer treated with cisplatin-vinorelbine A ELCWP prospective studyT Berghmans, L Ameye, L Willems, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 4, 2007
A phase III randomised trial comparing sequential chemotherapy using cisplatin-based regimen and paclitaxel to cisplatin-based chemotherapy alone in advanced non-small-cell lung cancerJ P Sculier, J J Lafitte, J Lecomte, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 28, 2008
A phase III randomised study of concomitant induction radiochemotherapy testing two modalities of radiosensitisation by cisplatin (standard versus daily) for limited small-cell lung cancerJ P Sculier, J J Lafitte, A Efremidis, et al.
Pageof 5